- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
BrightSpring Health Services
Market Cap: US$4.1b
Operates as a home and community-based healthcare services platform in the United States.
BTSG
US$24.02
7D
6.7%
1Y
110.7%
Bausch + Lomb
Market Cap: US$4.1b
Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.
BLCO
US$11.80
7D
2.6%
1Y
-22.6%
Krystal Biotech
Market Cap: US$3.8b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$130.33
7D
-5.0%
1Y
-20.4%
Vaxcyte
Market Cap: US$3.8b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$30.90
7D
-1.7%
1Y
-59.0%
PTC Therapeutics
Market Cap: US$3.7b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.
PTCT
US$45.31
7D
6.6%
1Y
33.1%
Soleno Therapeutics
Market Cap: US$3.7b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$75.07
7D
-1.6%
1Y
64.4%
Sotera Health
Market Cap: US$3.6b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$12.74
7D
-3.7%
1Y
11.7%
Rhythm Pharmaceuticals
Market Cap: US$3.6b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$57.28
7D
-11.4%
1Y
44.6%
Chartwell Retirement Residences
Market Cap: CA$5.0b
Chartwell is in the business of serving and caring for Canada's seniors, committed to its vision of Making People's Lives BETTER and to providing a happier, healthier, and more fulfilling life experience for its residents.
CSH.UN
CA$18.16
7D
3.0%
1Y
43.0%
Cytokinetics
Market Cap: US$3.6b
A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
CYTK
US$29.87
7D
-8.1%
1Y
-50.2%
Perrigo
Market Cap: US$3.6b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$26.29
7D
-1.9%
1Y
-12.7%
Sarepta Therapeutics
Market Cap: US$3.5b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
SRPT
US$35.27
7D
-3.4%
1Y
-73.4%
SpringWorks Therapeutics
Market Cap: US$3.5b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.
SWTX
US$46.08
7D
-0.3%
1Y
2.9%
Haemonetics
Market Cap: US$3.4b
A healthcare company, provides suite of medical products and solutions in the United States and internationally.
HAE
US$69.38
7D
2.0%
1Y
-26.8%
Avidity Biosciences
Market Cap: US$3.4b
A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
RNA
US$28.97
7D
1.0%
1Y
0.9%
1Life Healthcare
Market Cap: US$3.4b
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand.
ONEM
US$16.47
7D
7.3%
1Y
68.8%
ICU Medical
Market Cap: US$3.3b
Develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.
ICUI
US$140.54
7D
-1.6%
1Y
32.2%
DENTSPLY SIRONA
Market Cap: US$3.3b
Develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
XRAY
US$16.50
7D
3.7%
1Y
-41.9%
Ultragenyx Pharmaceutical
Market Cap: US$3.3b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE
US$34.84
7D
-3.2%
1Y
-18.2%
Arcellx
Market Cap: US$3.3b
Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
ACLX
US$58.45
7D
3.9%
1Y
10.7%
Alvotech
Market Cap: US$3.2b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$10.50
7D
32.2%
1Y
-21.3%
Amedisys
Market Cap: US$3.1b
Provides healthcare services in the United States.
AMED
US$93.72
7D
-1.6%
1Y
-1.3%
CRISPR Therapeutics
Market Cap: US$3.1b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
CRSP
US$36.31
7D
0.5%
1Y
-34.8%
Zai Lab
Market Cap: US$3.1b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$28.75
7D
-1.3%
1Y
44.3%
Envista Holdings
Market Cap: US$3.0b
Develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
NVST
US$18.09
7D
1.8%
1Y
-5.4%
Akero Therapeutics
Market Cap: US$3.0b
Engages in the development of treatments for patients with serious metabolic diseases in the United States.
AKRO
US$39.96
7D
-5.7%
1Y
92.8%
Ansell
Market Cap: AU$4.7b
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
ANN
AU$32.30
7D
1.6%
1Y
22.3%
Viking Therapeutics
Market Cap: US$3.0b
A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
VKTX
US$27.40
7D
-1.6%
1Y
-60.3%
Privia Health Group
Market Cap: US$3.0b
Operates as a national physician-enablement company in the United States.
PRVA
US$24.90
7D
-0.7%
1Y
46.5%
Alignment Healthcare
Market Cap: US$2.9b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$14.90
7D
-3.4%
1Y
113.2%
PROCEPT BioRobotics
Market Cap: US$2.9b
A surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.
PRCT
US$54.77
7D
3.1%
1Y
-20.8%
Crinetics Pharmaceuticals
Market Cap: US$2.9b
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
CRNX
US$31.21
7D
-4.6%
1Y
-39.9%
Scholar Rock Holding
Market Cap: US$2.9b
A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
SRRK
US$30.89
7D
-0.3%
1Y
115.7%
Surgery Partners
Market Cap: US$2.9b
Owns and operates a network of surgical facilities and ancillary services in the United States.
SGRY
US$23.64
7D
4.2%
1Y
-10.6%
ACADIA Pharmaceuticals
Market Cap: US$2.9b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$17.60
7D
4.0%
1Y
18.5%
Catalyst Pharmaceuticals
Market Cap: US$2.9b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$23.78
7D
4.5%
1Y
45.0%